Anthera Pharmaceuticals

(OTC: ANTH)
Healthcare  |  Biotechnology
0.04 -0.0804 -68.38%
Stock Price | Dec. 13, 2019, 3:53 p.m.
0 Followers
Bid: 0.0285
Ask: 0.038
Prev. Close: 0.1175
52 Week Low: 0.023
52 Week High: 0.1
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 12/30/2015

3 years ago

Premium Stock Watchlist 4/15/2015

4 years ago